4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001209191-20-032489
Options or other derivatives
- Chief Financial Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arcudi III Louis J Chief Financial Officer | 2020-05-25 | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | D | ||
Loading xslF345X03/doc4.xml…